Banque Cantonale Vaudoise’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$4K	–	1242
2022 Q4	$4K	Hold	5,000	–	–	﹤0.01%	1155
2022 Q3	$8K	Sell	5,000 -10,000	-67%	-$22.7K	﹤0.01%	1164
2022 Q2	$30K	Hold	15,000	–	–	﹤0.01%	1079
2022 Q1	$35K	Hold	15,000	–	–	﹤0.01%	1092
2021 Q4	$70K	Sell	15,000 -2,200	-13%	-$13.7K	﹤0.01%	1013
2021 Q3	$131K	Hold	17,200	–	–	0.01%	887
2021 Q2	$166K	Buy	17,200 +500	+3%	+$3.98K	0.01%	872
2021 Q1	$138K	Hold	16,700	–	–	0.01%	846
2020 Q4	$114K	Hold	16,700	–	–	0.01%	832
2020 Q3	$187K	Buy	+16,700	New	+$153K	0.01%	704

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return